Use of Electronic Personal Health Records to Improve Medication Adherence
The Use of Electronic Personal Health Records to Improve Medication Adherence Among Non-Valvular Atrial Fibrillation Patients: A Pilot Study
調査の概要
詳細な説明
Three brief newsletters will be sent by the research staff to the study patients in the form of secure messages through their MyChart account. The newsletters will describe dabigatran tolerability, adverse effects, patient monitoring, warnings/precautions, and administration. Newsletters will be developed through a review of the FDA-approved prescribing information, general tertiary references, and a search of PubMed and drafted with guidance from a Drug Information Specialist at Manchester University College of Pharmacy as well as reviewed by the research staff.
Descriptive analysis will be used to analyze the survey to assess patient attitudes and beliefs about dabigatran and personal health records, as well as to assess the level of patient engagement. Difference-in-difference regression analysis will be used to evaluate the impact of the personal health record on dabigatran adherence by comparing the differences between times (pre-post) and interventions. Patient medication adherence will be correlated from the Pharmacy refill data to determine if the Intervention Group is more compliant than the Control Group. Multivariate analysis will be used to explore factors influencing personal health record use and dabigatran adherence.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Indiana
-
Fort Wayne、Indiana、アメリカ、46845
- Parkview Research Center; Parkview Health
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age ≥ 18 years
- Patient of Parkview Physicians Group-Cardiology
- Currently on dabigatran for non-valvular atrial fibrillation
- Out-patient status
- Ability to read and understand English
- Access to the Internet
- Ability to utilize the computer and Internet
- Willingness to enroll in a MyChart account
Exclusion Criteria:
- Physical or cognitive disability hindering provision of the informed consent process or performance of study tasks
- Unable to physically or cognitively carry out the tasks necessary for activating and/or utilizing a personal health record
- Designated as part of a vulnerable subject population that the investigator or designee identifies to have compromised autonomy related to potential study participation
- Currently part of another study involving another type of personal health record (other than MyChart)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
実験的:Medication Education
Patients will receive training on the use of the personal health record and health education via the personal health record.
|
Medication education delivered via the personal health record (MyChart) pertinent to the anticoagulation medication dabigatran.
Education newsletters will be sent at 4, 6, and 10 weeks post-enrollment.
|
介入なし:No Medication Education
Patients will receive the current standard of care for the personal health record.
Patients will not receive training on the use of the personal health record or health education via the personal health record.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
---|---|
Medication Adherence evaluated through medication possession ratios
時間枠:3 months during study
|
3 months during study
|
二次結果の測定
結果測定 |
時間枠 |
---|---|
Patient Engagement evaluated through Patient Activation Measure (PAM)
時間枠:3 months during study
|
3 months during study
|
Medication Knowledge evaluated through 5-question survey
時間枠:3 months during study
|
3 months during study
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Michael Mirro, MD、Parkview Health
- 主任研究者:Ozlem Ersin, PhD、Manchester University College of Medicine
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Medication Educationの臨床試験
-
University of North Carolina, Chapel HillMedical University of South Carolina; National Institute of Mental Health (NIMH); University of... と他の協力者完了HIV/エイズ | 服薬アドヒアランス | HIV | 性的行動 | 性感染症 (HIV や肝炎ではない)アメリカ
-
Fondazione Poliambulanza Istituto Ospedalieroわからない
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of Melbourne積極的、募集していない
-
Smiths Medical, ASD, Inc.完了